These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 31407505)
1. Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results-based study. Tao L; Yu H; Dong Y; Tian G; Ren Z; Li D Cancer Med; 2019 Oct; 8(13):5872-5880. PubMed ID: 31407505 [TBL] [Abstract][Full Text] [Related]
2. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010. Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751 [TBL] [Abstract][Full Text] [Related]
3. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis. Bevier M; Sundquist J; Hemminki K Eur J Cancer Prev; 2012 Nov; 21(6):596-601. PubMed ID: 22387673 [TBL] [Abstract][Full Text] [Related]
4. Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults. Pavlidis N; Rassy E; Smith-Gagen J Int J Cancer; 2020 Mar; 146(6):1490-1498. PubMed ID: 31144291 [TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological characterization and autopsybased classification of the Cancer of Unknown Primary origin (CUP) syndrome]. Kocsmár É; Kocsmár I; Karczub J; Istók R; Kiss A; Schaff Z; Lotz G Magy Onkol; 2019 Jun; 63(2):75-84. PubMed ID: 31225530 [TBL] [Abstract][Full Text] [Related]
6. Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries. Hemminki K; Bevier M; Sundquist J; Hemminki A Int J Cancer; 2013 Feb; 132(4):944-50. PubMed ID: 22730111 [TBL] [Abstract][Full Text] [Related]
7. Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities. Urban D; Rao A; Bressel M; Lawrence YR; Mileshkin L Br J Cancer; 2013 Sep; 109(5):1318-24. PubMed ID: 23860528 [TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases]. Kato S; Yasuda K; Nishino Y; Ohori H; Takahashi M; Takahashi S; Yamaura G; Ohtsuka K; Kakudo Y; Chiba N; Shimodaira H; Sakayori M; Kato S; Suzuki T; Murakawa Y; Gamoh M; Shibata H; Yoshioka T; Ishioka C Gan To Kagaku Ryoho; 2007 Aug; 34(8):1227-31. PubMed ID: 17687203 [TBL] [Abstract][Full Text] [Related]
9. Effects of different metastasis patterns, surgery and other factors on the prognosis of patients with stage IV non-small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) linked database analysis. Liao Y; Fan X; Wang X Oncol Lett; 2019 Jul; 18(1):581-592. PubMed ID: 31289530 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis. Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases. Qi P; Sun Y; Liu X; Wu S; Wo Y; Xu Q; Wang Q; Hu X; Zhou X Cancer Med; 2023 Jan; 12(2):1177-1188. PubMed ID: 35822433 [TBL] [Abstract][Full Text] [Related]
12. [Cancer of unknown primary site origin--advances in diagnosis and therapy]. Plot L; Dovrish Z; Hadari R; Weisenberg N; Zehavi T; Nisenbaum B; Amital H Harefuah; 2008 Apr; 147(4):294-8, 376, 375. PubMed ID: 18686808 [TBL] [Abstract][Full Text] [Related]
14. Stage IV melanoma of unknown primary: A population-based study in the United States from 1973 to 2014. Scott JF; Conic RZ; Thompson CL; Gerstenblith MR; Bordeaux JS J Am Acad Dermatol; 2018 Aug; 79(2):258-265.e4. PubMed ID: 29580859 [TBL] [Abstract][Full Text] [Related]
15. Location of metastases in cancer of unknown primary are not random and signal familial clustering. Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545 [TBL] [Abstract][Full Text] [Related]
16. Age-Dependent Metastatic Spread and Survival: Cancer of Unknown Primary as a Model. Hemminki K; Pavlidis N; Tsilidis KK; Sundquist K; Ji J Sci Rep; 2016 Mar; 6():23725. PubMed ID: 27009354 [TBL] [Abstract][Full Text] [Related]
17. Cancer of unknown primary: time trends in incidence, United States. Mnatsakanyan E; Tung WC; Caine B; Smith-Gagen J Cancer Causes Control; 2014 Jun; 25(6):747-57. PubMed ID: 24710663 [TBL] [Abstract][Full Text] [Related]
18. Cancer of unknown primary site: 20 questions to be answered. Pavlidis N; Pentheroudakis G Ann Oncol; 2010 Oct; 21 Suppl 7():vii303-7. PubMed ID: 20943633 [TBL] [Abstract][Full Text] [Related]
19. Survival outcomes following craniotomy for intracranial metastases from an unknown primary. Gough M; Nielsen M; Coulter IC; Holliman D Int J Clin Oncol; 2020 Aug; 25(8):1475-1482. PubMed ID: 32358736 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic strategies in cervical carcinoma of an unknown primary (CUP). Haas I; Hoffmann TK; Engers R; Ganzer U Eur Arch Otorhinolaryngol; 2002 Jul; 259(6):325-33. PubMed ID: 12115082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]